WATSON 3159 Pill - white capsule/oblong, 22mm
Pill with imprint WATSON 3159 is White, Capsule/Oblong and has been identified as Ursodiol 300 mg. It is supplied by Watson Pharmaceuticals.
Ursodiol is used in the treatment of Primary Biliary Cholangitis ; Gallbladder Disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3159
Ursodiol
- Imprint
- WATSON 3159
- Strength
- 300 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Gallstone solubilizing agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
ferric oxide red,
gelatin,
magnesium stearate,
corn starch,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3159 | Watson Pharmaceuticals, Inc. |
| 68084-0213 (Discontinued) | Amerisource Health Services |
More about ursodiol
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (31)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: gallstone solubilizing agents
- Breastfeeding
- En español
Patient resources
Other brands
Actigall, Urso, Urso Forte, Reltone
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
